Nutritionally variant streptococci: Difference between revisions
From IDWiki
(Created page with "== Background == * Require pyridoxine (vitamin B6) supplementation to group * Also called pyridoxal-dependent or stalliting streptococci == Organisms == * ''Abiotrophia def...") |
m (Text replacement - "Clinical Presentation" to "Clinical Manifestations") |
||
| Line 9: | Line 9: | ||
* ''[[Granulicatella para-adiacens]]'' |
* ''[[Granulicatella para-adiacens]]'' |
||
| − | == Clinical |
+ | == Clinical Manifestations == |
* [[Subacute bacterial endocarditis]] is the most well-known disease association |
* [[Subacute bacterial endocarditis]] is the most well-known disease association |
||
Revision as of 08:14, 19 July 2020
Background
- Require pyridoxine (vitamin B6) supplementation to group
- Also called pyridoxal-dependent or stalliting streptococci
Organisms
Clinical Manifestations
- Subacute bacterial endocarditis is the most well-known disease association
References
- ^ Taisei Kanamoto, Shigemi Terakubo, Hideki Nakashima. Antimicrobial Susceptibilities of Oral Isolates of Abiotrophia and Granulicatella According to the Consensus Guidelines for Fastidious Bacteria. Medicines. 2018;5(4):129. doi:10.3390/medicines5040129.
- ^ Kunatum Prasidthrathsint, Mark A. Fisher. Robin Patel. Antimicrobial Susceptibility Patterns among a Large, Nationwide Cohort of Abiotrophia and Granulicatella Clinical Isolates. Journal of Clinical Microbiology. 2017;55(4):1025-1031. doi:10.1128/jcm.02054-16.
- ^ Ammara Mushtaq, Kerryl E. Greenwood-Quaintance, Nicolynn C. Cole, Peggy C. Kohner, Sherry M. Ihde, Gregory J. Strand, Lance W. Harper, Abinash Virk, Robin Patel. Differential Antimicrobial Susceptibilities of Granulicatella adiacens and Abiotrophia defectiva. Antimicrobial Agents and Chemotherapy. 2016;60(8):5036-5039. doi:10.1128/aac.00485-16.
